Clinical Trial Update: Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-Lymphotropic Virus 1 [Phase 4]

View source ↗

Summary

Phase 4 trial update on combining darifenacin with parasacral transcutaneous electrical nerve stimulation for overactive bladder in HTLV-1 infected patients. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human T-lymphotropic Virus Type Infection
• Overactive Bladder

Drugs mentioned

• Darifenacin (darifenacin)
• Parasacral transcutaneous electrical nerve stimulation

Snippet

Sponsor: Hospital Universitário Professor Edgard Santos | Conditions: HTLV-1, Overactive Bladder Syndrome | Phase 4 | Status: COMPLETED